Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
Sales | 21,688 | 9,906 | 5,713 | 6,094 | 0 |
Gross Profit | 21,688 | 9,906 | 5,713 | 6,094 | N/A |
Operating Expenses | 42,986 | 26,013 | 25,402 | 69,470 | 0 |
Operating Income | -21,298 | -16,107 | -19,689 | -63,376 | N/A |
Interest Expense | 1 | 224 | 965 | 541 | 0 |
Other Income | 801 | 760 | 295 | 61 | 0 |
Pre-tax Income | -20,498 | -15,571 | -20,359 | -63,856 | 0 |
Income Tax | -791 | 2,066 | N/A | N/A | N/A |
Net Income Continuous | -19,707 | -17,637 | -20,359 | -63,856 | N/A |
Net Income | $-19,707 | $-17,637 | $-20,359 | $-63,856 | $N/A |
EPS Basic Total Ops | -3.54 | -0.48 | N/A | N/A | N/A |
EPS Basic Continuous Ops | -3.53 | -0.48 | N/A | N/A | N/A |
EPS Diluted Total Ops | -3.54 | -0.48 | N/A | N/A | N/A |
EPS Diluted Continuous Ops | -3.53 | -0.48 | N/A | N/A | N/A |
EBITDA(a) | $-21,054 | $-15,879 | $-19,517 | $-63,293 | $N/A |